2vh5
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
- | {{Seed}} | ||
[[Image:2vh5.png|left|200px]] | [[Image:2vh5.png|left|200px]] | ||
Line 10: | Line 9: | ||
{{STRUCTURE_2vh5| PDB=2vh5 | SCENE= }} | {{STRUCTURE_2vh5| PDB=2vh5 | SCENE= }} | ||
- | ===CRYSTAL STRUCTURE OF HRAS(G12V)- ANTI-RAS FV (DISULFIDE FREE MUTANT) COMPLEX=== | + | ===CRYSTAL STRUCTURE OF HRAS(G12V) - ANTI-RAS FV (DISULFIDE FREE MUTANT) COMPLEX=== |
Line 20: | Line 19: | ||
==About this Structure== | ==About this Structure== | ||
- | + | [[2vh5]] is a 3 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2VH5 OCA]. | |
==Reference== | ==Reference== | ||
Line 33: | Line 32: | ||
[[Category: Golgi apparatus]] | [[Category: Golgi apparatus]] | ||
[[Category: Gtp-binding]] | [[Category: Gtp-binding]] | ||
+ | [[Category: Immune system]] | ||
[[Category: Immunoglobulin domain]] | [[Category: Immunoglobulin domain]] | ||
[[Category: Intrabody]] | [[Category: Intrabody]] | ||
Line 39: | Line 39: | ||
[[Category: Methylation]] | [[Category: Methylation]] | ||
[[Category: Nucleotide- binding]] | [[Category: Nucleotide- binding]] | ||
- | [[Category: Nucleotide-binding | + | [[Category: Nucleotide-binding]] |
[[Category: Oncogene]] | [[Category: Oncogene]] | ||
[[Category: Palmitate]] | [[Category: Palmitate]] | ||
Line 46: | Line 46: | ||
[[Category: Signal transduction]] | [[Category: Signal transduction]] | ||
[[Category: Signaling protein/immune system]] | [[Category: Signaling protein/immune system]] | ||
- | |||
- | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Feb 18 08:01:29 2009'' |
Revision as of 19:43, 14 March 2011
CRYSTAL STRUCTURE OF HRAS(G12V) - ANTI-RAS FV (DISULFIDE FREE MUTANT) COMPLEX
Template:ABSTRACT PUBMED 18187153
About this Structure
2vh5 is a 3 chain structure with sequence from Homo sapiens. Full crystallographic information is available from OCA.
Reference
- Tanaka T, Rabbitts TH. Functional intracellular antibody fragments do not require invariant intra-domain disulfide bonds. J Mol Biol. 2008 Feb 22;376(3):749-57. Epub 2007 Dec 4. PMID:18187153 doi:10.1016/j.jmb.2007.11.085
- Tanaka T, Williams RL, Rabbitts TH. Tumour prevention by a single antibody domain targeting the interaction of signal transduction proteins with RAS. EMBO J. 2007 Jul 11;26(13):3250-9. Epub 2007 Jun 14. PMID:17568777
Categories: Homo sapiens | Rabbitts, T H. | Tanaka, T. | Williams, R L. | Antibody | Cancer therapy | Disease mutation | Golgi apparatus | Gtp-binding | Immune system | Immunoglobulin domain | Intrabody | Lipoprotein | Membrane | Methylation | Nucleotide- binding | Nucleotide-binding | Oncogene | Palmitate | Prenylation | Proto-oncogene | Signal transduction | Signaling protein/immune system